Psychiatry and Neurology, Neurology · Columbus, OH
NPI
1992799167
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1480 W Lane Ave
Columbus, OH, 43221
Phone (614) 533-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$164K
22,159 services
Medicare patients, 2024
338
Average age 70
Drug cost, 2024
$2.2M
1,821 prescriptions
Company payments, 2025
$92K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geoffrey A Eubank was code J0585 (injection, onabotulinumtoxina, 1 unit), 20,880 times for 33 patients. In total Geoffrey A Eubank billed 22,159 services in 38 codes, and Medicare paid $164K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 20,880 | 33 | $4.94 | $103K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 206 | 187 | $12.58 | $2,592 |
| 99215 Office E&M - Established | Office | 107 | 96 | $125.99 | $13K |
| 99214 Office E&M - Established | Office | 77 | 74 | $90.36 | $6,958 |
| 99223 Hospital E&M - Initial | Facility | 51 | 51 | $137.08 | $6,991 |
| 95874 Musculoskeletal | Office | 48 | 21 | $49.43 | $2,373 |
| 99204 Office E&M - New | Office | 36 | 36 | $115.62 | $4,162 |
| 64615 Musculoskeletal | Office | 34 | 12 | $108.22 | $3,679 |
| 64644 Musculoskeletal | Office | 32 | 13 | $121.00 | $3,872 |
| 99205 Office E&M - New | Office | 17 | 17 | $164.68 | $2,800 |
| 95819 Neurologic | Facility | 13 | 13 | $40.92 | $532 |
| 99213 Office E&M - Established | Office | 12 | 12 | $51.77 | $621 |
By year: 2022 $172K for 24,031 services; 2023 $161K for 22,206 services; 2024 $164K for 22,159 services.
Medicare prescription drug claims, 2024
In 2024, the drug Geoffrey A Eubank prescribed most often to Medicare patients was Gabapentin, with 173 prescriptions and refills. In total Geoffrey A Eubank wrote 1,821 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 173 | 293 | 46 | $4,463 |
| Levetiracetam Generic | 165 | 307 | 32 | $6,240 |
| Baclofen Generic | 152 | 282 | 45 | $3,079 |
| Donepezil Hcl Generic | 75 | 122 | 19 | $610 |
| Lamotrigine Generic | 72 | 146 | 13 | $1,005 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 61 | 139 | 16 | $1,467 |
| Topiramate Generic | 57 | 131 | 14 | $510 |
| Pregabalin Generic | 50 | 52 | Under 11 | $497 |
| Teriflunomide Generic | 46 | 52 | Under 11 | $57K |
| Lacosamide Generic | 45 | 59 | Under 11 | $4,101 |
| Tizanidine Hcl Generic | 44 | 75 | Under 11 | $868 |
| Dalfampridine Er Dalfampridine | 40 | 66 | Under 11 | $26K |
| Carbamazepine Er Carbamazepine | 39 | 82 | Under 11 | $8,799 |
| Primidone Generic | 38 | 49 | Under 11 | $1,271 |
| Amitriptyline Hcl Generic | 38 | 57 | 12 | $441 |
Brand drugs: - claims; generic drugs: 1,585 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Geoffrey A Eubank $92K ($92K in general payments such as food, travel and fees) from 12 companies. The largest payer was EMD Serono, Inc. with $64K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 73 | $64K |
| TG Therapeutics, Inc. TGTX | 29 | $22K |
| Amgen Inc. AMGN | 5 | $4,699 |
| Genzyme Corporation SNY | 3 | $323 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $290 |
| Genentech USA, Inc. ROG.SW | 2 | $186 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $167 |
| Biogen, Inc. BIIB | 2 | $153 |
| Abbvie Inc. ABBV | 1 | $115 |
| Neurelis, Inc. | 1 | $83.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.